Oncolytic Herpes Viral Therapy is Effective in the Treatment of Hepatocellular Carcinoma Cell Lines
- 30 April 2006
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 10 (4) , 532-542
- https://doi.org/10.1016/j.gassur.2005.08.036
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Hepatocellular carcinomaPublished by Elsevier ,2000
- Corticosteroid Administration Does Not Affect Viral Oncolytic Activity, but Inhibits Antitumor Immunity in ReplicationCompetent Herpes Simplex Virus Tumor TherapyHuman Gene Therapy, 1999
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- Mutation ofp53 gene in hepatocellular carcinoma cell lines with HBX DNAInternational Journal of Cancer, 1996
- Enhancement of Gene Therapy Specificity for Diffuse Colon Carcinoma Liver Metastases with Recombinant Herpes Simplex VirusAnnals of Surgery, 1996
- Characterization of cell lines established from human hepatocellular carcinomaInternational Journal of Cancer, 1995
- Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaAnnals of Hematology, 1995
- Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinomaCancer, 1995
- Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.Journal of Clinical Investigation, 1993
- Variation in EGF-induced EGF receptor downregulation in human hepatoma-derived cell lines expressing different amounts of EGF receptorExperimental Cell Research, 1992